Transaction #1964 · Form 4 · 0001916473-25-000008

Elanco Animal Health Inc · Stock award · Deferred Stock Units

Elanco Animal Health Inc · Transacted October 17, 2025 · Filed October 21, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Elanco Animal Health Inc records a stock award involving Deferred Stock Units on October 17, 2025. The reported quantity was 66.042. The filing date is October 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001739104
Security type
Derivative
Acquisition type
Stock award · Code A
Quantity acquired
66.042
Reported price
21.42
Reference value
1,414.61964
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
7,099.3043
Ownership description
Not reported
SEC acceptance time
Oct 21, 2025, 4:21 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

ELAN · NYSE

This transaction is not mapped to a specific company listing.

Derivative terms

Underlying security
Common Stock
Underlying quantity
66.042
Conversion / exercise price
Not reported
Exercise date
Not reported
Expiration date
Not reported

Filing footnotes & remarks

F1
Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2
Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Remarks

Executive Vice President U.S. Pet Health and Global Digital Transformation

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.